Anthracyclines--modern tumour-inhibiting agents
- PMID: 348587
- DOI: 10.1007/BF02915316
Anthracyclines--modern tumour-inhibiting agents
Similar articles
-
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.Cancer Treat Rep. 1986 Jan;70(1):51-63. Cancer Treat Rep. 1986. PMID: 2935251 Review. No abstract available.
-
Biologic properties of three anthracyclines as a function of lipophilicity.Biochem Pharmacol. 1979 Oct 1;28(19):3028-30. doi: 10.1016/0006-2952(79)90606-3. Biochem Pharmacol. 1979. PMID: 518699 No abstract available.
-
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.J Clin Pharmacol. 1986 Sep-Oct;26(7):491-509. doi: 10.1002/j.1552-4604.1986.tb02942.x. J Clin Pharmacol. 1986. PMID: 2944917 Review.
-
Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1127-8. Cancer Treat Rep. 1980. PMID: 6109566 No abstract available.
-
New anthracycline glycosides from Micromonospora. II. isolation, characterization and biological properties.J Antibiot (Tokyo). 1980 Dec;33(12):1468-73. doi: 10.7164/antibiotics.33.1468. J Antibiot (Tokyo). 1980. PMID: 6941955
Cited by
-
Metabolic products of microorganisms. 185. The anthraquinones of the Aspergillus glaucus group. I. Occurrence, isolation, identification and antimicrobial activity.Arch Microbiol. 1980 Jul;126(3):223-30. doi: 10.1007/BF00409924. Arch Microbiol. 1980. PMID: 7406630
-
Intergeneric conjugation in Streptomyces peucetius and Streptomyces sp. strain C5: chromosomal integration and expression of recombinant plasmids carrying the chiC gene.Appl Environ Microbiol. 2003 Jan;69(1):84-91. doi: 10.1128/AEM.69.1.84-91.2003. Appl Environ Microbiol. 2003. PMID: 12513980 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources